- Home
- Publications
- Publication Search
- Publication Details
Title
Trial Watch
Authors
Keywords
-
Journal
OncoImmunology
Volume 2, Issue 7, Pages e24850
Publisher
Informa UK Limited
Online
2013-08-20
DOI
10.4161/onci.24850
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TP53 and MTOR crosstalk to regulate cellular senescence
- (2016) Lorenzo Galluzzi et al. Aging-US
- Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF)
- (2013) Arash Naeim et al. BMC CANCER
- Harnessing the Immune System for the Treatment of Non–Small-Cell Lung Cancer
- (2013) Julie R. Brahmer JOURNAL OF CLINICAL ONCOLOGY
- Plasma Cytokine Profiles at Diagnosis in Pediatric Patients With Non-Hodgkin Lymphoma
- (2013) Karin Mellgren et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- T-helper-1-cell cytokines drive cancer into senescence
- (2013) Heidi Braumüller et al. NATURE
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Interstitial Dendritic Cell Guidance by Haptotactic Chemokine Gradients
- (2013) M. Weber et al. SCIENCE
- Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer
- (2013) Weiyi Peng et al. OncoImmunology
- Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients
- (2013) Patricia Pautier et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Laurie Menger et al. OncoImmunology
- Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma
- (2012) Maike Sauer et al. AMERICAN JOURNAL OF HEMATOLOGY
- Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients
- (2012) Stephen M. Ansell et al. AMERICAN JOURNAL OF HEMATOLOGY
- VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients
- (2012) Jon E. Peterson et al. ANGIOGENESIS
- Hyperthermic Pelvic Perfusion With Tumor Necrosis Factor-α for Locally Advanced Cancers
- (2012) Sylvie Bonvalot et al. ANNALS OF SURGERY
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Optimization of Multivalent Bispecific Antibodies and Immunocytokines with Improved in Vivo Properties
- (2012) Edmund A. Rossi et al. BIOCONJUGATE CHEMISTRY
- Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine
- (2012) T. Pabst et al. BLOOD
- A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer
- (2012) N Steele et al. BRITISH JOURNAL OF CANCER
- Phase I and pharmacodynamic study of high-dose NGR–hTNF in patients with refractory solid tumours
- (2012) P A Zucali et al. BRITISH JOURNAL OF CANCER
- Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients
- (2012) D Lorusso et al. BRITISH JOURNAL OF CANCER
- Targeting the Endothelin Axis with Atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma
- (2012) G Groenewegen et al. BRITISH JOURNAL OF CANCER
- Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study
- (2012) S Sleijfer et al. BRITISH JOURNAL OF CANCER
- Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults
- (2012) Martina Buehrlen et al. CANCER
- Phase II trial of hu14.18-IL2 for patients with metastatic melanoma
- (2012) Mark R. Albertini et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients
- (2012) Hidekazu Kameshima et al. CANCER SCIENCE
- Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer
- (2012) Q.-T. Le et al. CLINICAL CANCER RESEARCH
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Immunocytokines: a novel class of potent armed antibodies
- (2012) Nadine Pasche et al. DRUG DISCOVERY TODAY
- A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)
- (2012) C. Sebban et al. EUROPEAN JOURNAL OF CANCER
- A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours
- (2012) Silke Gillessen et al. EUROPEAN JOURNAL OF CANCER
- Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase I/II clinical trial
- (2012) Eliane C.M. Zeestraten et al. INTERNATIONAL JOURNAL OF CANCER
- Interleukin-21 Has Activity in Patients With Metastatic Melanoma: A Phase II Study
- (2012) Teresa M. Petrella et al. JOURNAL OF CLINICAL ONCOLOGY
- Open-Label, Multicenter, Randomized Phase III Trial of Adjuvant Chemoradiation Plus Interferon Alfa-2b Versus Fluorouracil and Folinic Acid for Patients With Resected Pancreatic Adenocarcinoma
- (2012) Jan Schmidt et al. JOURNAL OF CLINICAL ONCOLOGY
- Cost-Utility Analysis of Primary Prophylaxis Versus Secondary Prophylaxis With Granulocyte Colony-Stimulating Factor in Elderly Patients With Diffuse Aggressive Lymphoma Receiving Curative-Intent Chemotherapy
- (2012) Kelvin K.W. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma
- (2012) Alexander M.M. Eggermont et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Impact of Immune Microenvironment in Stage I Lung Adenocarcinoma: Tumor Interleukin-12 Receptor β2 (IL-12Rβ2), IL-7R, and Stromal FoxP3/CD3 Ratio Are Independent Predictors of Recurrence
- (2012) Kei Suzuki et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Prostate Tumor Antigen-Specific CD8+ Regulatory T Cells Are Inhibited by CTLA-4 or IL-35 Blockade
- (2012) B. M. Olson et al. JOURNAL OF IMMUNOLOGY
- Differential Immunologic and MicroRNA Effects of 2 Dosing Regimens of Recombinant Human Granulocyte/Macrophage Colony Stimulating Factor
- (2012) Pierre L. Triozzi et al. JOURNAL OF IMMUNOTHERAPY
- Differing Patterns of Circulating Regulatory T Cells and Myeloid-derived Suppressor Cells in Metastatic Melanoma Patients Receiving Anti-CTLA4 Antibody and Interferon-α or TLR-9 Agonist and GM-CSF With Peptide Vaccination
- (2012) Ahmad A. Tarhini et al. JOURNAL OF IMMUNOTHERAPY
- Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
- (2012) Alfons JM van den Eertwegh et al. LANCET ONCOLOGY
- Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
- (2012) Hai T Tran et al. LANCET ONCOLOGY
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- Hepatitis E vaccine debuts
- (2012) Soo Bin Park NATURE
- IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
- (2012) Samuel Huber et al. NATURE
- Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
- (2012) Sergei I. Grivennikov et al. NATURE
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- (2012) Timothy R. Wilson et al. NATURE
- Inflammasomes in carcinogenesis and anticancer immune responses
- (2012) Laurence Zitvogel et al. NATURE IMMUNOLOGY
- Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia
- (2012) Alex Kentsis et al. NATURE MEDICINE
- USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma
- (2012) Pieter J A Eichhorn et al. NATURE MEDICINE
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
- (2012) Mélanie Bruchard et al. NATURE MEDICINE
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia
- (2012) E Lainey et al. ONCOGENE
- Sequential Local Injection of Low-Dose Interferon-Beta for Maintenance Therapy in Stage II and III Melanoma: A Single-Institution Matched Case-Control Study
- (2012) Satoru Aoyagi et al. ONCOLOGY
- Prognostic Role of Serum Cytokines in Patients with Nasopharyngeal Carcinoma
- (2012) Ke Lu et al. ONKOLOGIE
- In vivo Expansion of Naïve CD4+CD25high FOXP3+ Regulatory T Cells in Patients with Colorectal Carcinoma after IL-2 Administration
- (2012) Marc Beyer et al. PLoS One
- Interleukin-10 Haplotype May Predict Survival and Relapse in Resected Non-Small Cell Lung Cancer
- (2012) Yaw-Cheng Wang et al. PLoS One
- Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2--Tumor and Immunological Responses
- (2012) S. K. Seung et al. Science Translational Medicine
- Tumor-infiltrating lymphocytes and outcome in Merkel cell carcinoma, a virus-associated cancer
- (2012) Harri Sihto et al. OncoImmunology
- Interleukin-21 in cancer immunotherapy
- (2012) Carmine Stolfi et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination
- (2012) Goodwin Jinesh G. et al. OncoImmunology
- Chemoimmunotherapy as long-term maintenance therapy for cancer
- (2012) Nejat K. Egilmez et al. OncoImmunology
- Interleukin 21 impairs tumor immunosurveillance of colitis-associated colorectal cancer
- (2012) Rebecca Kesselring et al. OncoImmunology
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
- (2012) Erika Vacchelli et al. OncoImmunology
- Targeting PD-1/PD-L1 interactions for cancer immunotherapy
- (2012) Laurence Zitvogel et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma
- (2011) A. J. Zurita et al. ANNALS OF ONCOLOGY
- 20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters
- (2011) Jan P. Deroose et al. ANNALS OF SURGICAL ONCOLOGY
- Phase I/II trial of subcutaneous interleukin-2, granulocyte-macrophage colony-stimulating factor and interferon-α in patients with metastatic renal cell carcinoma
- (2011) Jorge A. Garcia et al. BJU INTERNATIONAL
- Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases
- (2011) J. P. Deroose et al. BRITISH JOURNAL OF SURGERY
- Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion
- (2011) Kazuhiro Kasai et al. CANCER
- A phase 2 study of pegylated interferon α-2b (PEG-Intron®) in children with diffuse intrinsic pontine glioma
- (2011) Katherine Warren et al. CANCER
- Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate “Natural” and “Inducible” CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer
- (2011) Mark J. Dobrzanski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Exploiting antitumor immunity to overcome relapse and improve remission duration
- (2011) Lei L. Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients
- (2011) Osama E. Rahma et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia
- (2011) Sylvain Thépot et al. CELL CYCLE
- Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial
- (2011) A. M. Lim et al. CLINICAL CANCER RESEARCH
- Treatment with Interferon alpha prior to discontinuation of Imatinib in patients with chronic myeloid leukemia
- (2011) Izhar Hardan et al. CYTOKINE
- Ulceration and stage are predictive of interferon efficacy in melanoma: Results of the phase III adjuvant trials EORTC 18952 and EORTC 18991
- (2011) Alexander M.M. Eggermont et al. EUROPEAN JOURNAL OF CANCER
- Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma
- (2011) Ahmad A. Tarhini et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia
- (2011) D A Pollyea et al. LEUKEMIA
- Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial
- (2011) B. Walter et al. MEDICAL ONCOLOGY
- Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
- (2011) Nicolas F Delahaye et al. NATURE MEDICINE
- Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
- (2011) Vinod P Balachandran et al. NATURE MEDICINE
- Rituximab for follicular lymphoma: maintaining an open mind
- (2011) Bruce D. Cheson Nature Reviews Clinical Oncology
- Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature
- (2011) Paola Scaruffi et al. PEDIATRIC BLOOD & CANCER
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Ofatumumab
- (2010) Michael J. Keating et al. NATURE REVIEWS DRUG DISCOVERY
- Advanced Malignant Melanoma: Immunologic and Multimodal Therapeutic Strategies
- (2010) Niels Halama et al. Journal of Oncology
- Natural Killer Cell IFN- Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor-Bearing Patients
- (2009) C. Menard et al. CANCER RESEARCH
- The High-Dose Aldesleukin (IL-2) “Select” Trial: A Trial Designed to Prospectively Validate Predictive Models of Response to High-Dose IL-2 Treatment in Patients With Metastatic Renal Cell Carcinoma
- (2009) Jessica M. Clement et al. Clinical Genitourinary Cancer
- Tocilizumab
- (2009) Clemens Scheinecker et al. NATURE REVIEWS DRUG DISCOVERY
- Hematopoietic cytokines
- (2008) D. Metcalf BLOOD
- In This Issue
- (2008) CELL
- Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development
- (2008) U. Sahin et al. CLINICAL CANCER RESEARCH
- Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
- (2008) Alexander MM Eggermont et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now